Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Domperidone for Functional Dyspepsia in Chinese Adults
NCT03617016Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Aug 2018
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of domperidone in functional dyspepsia (FD), sponsored by Janssen Pharmaceutical. Started Aug 2018; status: completed.
02
Drugs
domperidone
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on NCT03617016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03617016.